John C. Moore
Corporate Officer/Principal chez TearSolutions, Inc.
Profil
John C.
Moore's current job is as a Member-Observer Board at TearSolutions, Inc. His former jobs include being the President & Chief Executive Officer at Laser Diagnostic Technologies, Inc. from 2000 to 2004, Chief Executive Officer at Notal Vision Ltd.
from 2005 to 2007, Chairman at Optovue, Inc. from 2007 to 2016, and Independent Director at STAAR Surgical Co. from 2008 to 2021.
He also held positions at Coherent, Inc., Alcon Laboratories, Inc., and Carl Zeiss AG.
Mr. Moore completed his undergraduate degree at the University of Rochester.
Postes actifs de John C. Moore
| Sociétés | Poste | Début |
|---|---|---|
TearSolutions, Inc.
 TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | 01/12/2018 |
Anciens postes connus de John C. Moore
| Sociétés | Poste | Fin |
|---|---|---|
| STAAR SURGICAL COMPANY | Directeur/Membre du Conseil | 24/06/2021 |
Optovue, Inc.
 Optovue, Inc. Medical SpecialtiesHealth Technology Optovue, Inc. develops ophthalmic diagnosis instruments based on the Fourier-Domain OCT technology. Its products include Avanti, RTVue Premier, iFusion, iVue, iCam, iScan, iStand and Networking. The company was founded by Jay Wei and Tom Zhao in 2003 and is headquartered in Fremont, CA. | Président | 01/03/2016 |
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Directeur Général | 01/01/2007 |
Laser Diagnostic Technologies, Inc.
 Laser Diagnostic Technologies, Inc. Medical SpecialtiesHealth Technology Laser Diagnostic Technologies, Inc. developed and manufactured diagnostic laser equipment for the eye care industry. The company was headquartered in San Diego, CA. | Directeur Général | 01/01/2004 |
| COHERENT, INC. | Corporate Officer/Principal | - |
Formation de John C. Moore
| Rochester Christian University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STAAR SURGICAL COMPANY | Health Technology |
| Entreprise privées | 7 |
|---|---|
Coherent, Inc.
 Coherent, Inc. Industrial MachineryProducer Manufacturing Coherent, Inc. is a provider of laser solutions and optics for microelectronics, life sciences, industrial manufacturing, scientific and aerospace, and defense markets. It operates through the following business segments: OEM Laser Sources (OLS) and Industrial Lasers & Systems (ILS). The OLS segment focuses on laser sources and complex optical sub-systems, typically used in microelectronics manufacturing, medical diagnostics, and therapeutic medical applications. The ILS segment covers laser sources, sub-systems, and tools, which are used for industrial laser materials processing. The company was founded by Eugene Watson on May 26, 1966, and is headquartered in Santa Clara, CA. | Producer Manufacturing |
Optovue, Inc.
Optovue, Inc. Medical SpecialtiesHealth Technology Optovue, Inc. develops ophthalmic diagnosis instruments based on the Fourier-Domain OCT technology. Its products include Avanti, RTVue Premier, iFusion, iVue, iCam, iScan, iStand and Networking. The company was founded by Jay Wei and Tom Zhao in 2003 and is headquartered in Fremont, CA. | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Carl Zeiss AG
 Carl Zeiss AG Electronic ComponentsElectronic Technology Carl Zeiss AG engages in the development and manufacture of scientific optics technologies and solutions services. Its products and solutions inlcude medical, microscopy, optemetry, industrial metrology spectroscopy, semicondictor technology, camera and film lenses, and simulation solutions planetariums. The company was founded by Carl Zeiss in 1846 and is headquartered in Oberkochen, Germany. | Electronic Technology |
Laser Diagnostic Technologies, Inc.
Laser Diagnostic Technologies, Inc. Medical SpecialtiesHealth Technology Laser Diagnostic Technologies, Inc. developed and manufactured diagnostic laser equipment for the eye care industry. The company was headquartered in San Diego, CA. | Health Technology |
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Health Technology |